Preparation of 5-fluorouracil microparticles and 5-fluorouracil/poly(L-lactide) composites by a supercritical CO2 antisolvent process

被引:20
|
作者
Cuadra, Isaac A. [1 ]
Zahran, Fouad [1 ,2 ]
Martin, Daniel [1 ]
Cabanas, Albertina [1 ]
Pando, Concepcion [1 ]
机构
[1] Univ Complutense, Dept Quim Fis, E-28040 Madrid, Spain
[2] Helwan Univ, Fac Sci, Chem Dept, El Cairo, Egypt
来源
JOURNAL OF SUPERCRITICAL FLUIDS | 2019年 / 143卷
关键词
5-Fluorouracil; Supercritical CO2; Poly(L-lactide); Supercritical antisolvent; Controlled delivery; CARBON-DIOXIDE; DRUG-DELIVERY; RELEASE; FLUIDS; COPRECIPITATION; NANOPARTICLES; MECHANISMS; ENCAPSULATION; FUNDAMENTALS; SOLUBILITY;
D O I
10.1016/j.supflu.2018.07.027
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Microparticles of the anticancer drug 5-fluorouracil (5-Fu) were successfully prepared by supercritical antisolvent (SAS) precipitation using dimethylsulfoxide as solvent. The effect on particle size (PS) of the experiment parameters was studied. The conditions of temperature and pressure were the most important factors. Mean PS values ranged from 220 to 670 nm. Using as solvent a dimethylsulftudde + dichloromethane mixture, the SAS process was also used to obtain composite particles in which 5-Fu crystals are coated by a layer of poly(L-lactide) spheres. The particle morphology was studied by SEM. Other characterization included powder X-ray diffraction, DSC, TGA, and the measurement of the dissolution profiles. The composite particles were shown to provide a controlled delivery system.
引用
收藏
页码:64 / 71
页数:8
相关论文
共 50 条
  • [41] Injectable and Thermosensitive Poly(organophosphazene) Hydrogels for a 5-Fluorouracil Delivery
    Lee, Sun Mi
    Chun, Chang Ju
    Heo, Jeong Yun
    Song, Soo-Chang
    JOURNAL OF APPLIED POLYMER SCIENCE, 2009, 113 (06) : 3831 - 3839
  • [42] Studies on microencapsulation of 5-fluorouracil with poly(ortho ester) polymers
    Lin, Y.-H.E.
    Vasavada, R.C.
    2000, Taylor and Francis Ltd (17)
  • [43] EFFECT OF CO-ADMINISTRATION OF THYMINE OR THYMIDINE ON THE ANTI-TUMOR ACTIVITY OF 1-(2-TETRAHYDROFURYL)-5-FLUOROURACIL AND 5-FLUOROURACIL
    FUJII, S
    KITANO, S
    IKENAKA, K
    FUKUSHIMA, M
    NAKAMURA, H
    MAEHARA, Y
    SHIRASAKA, T
    GANN, 1980, 71 (01): : 100 - 106
  • [44] Poly(ε-caprolactone) with pH and UCST responsiveness as a 5-fluorouracil carrier
    Zhu, Shuang
    Wen, Lianlei
    Xiao, Yan
    Lang, Meidong
    POLYMER CHEMISTRY, 2020, 11 (32) : 5173 - 5180
  • [45] Studies on microencapsulation of 5-fluorouracil with poly(ortho ester) polymers
    Lin, YHE
    Vasavada, RC
    JOURNAL OF MICROENCAPSULATION, 2000, 17 (01) : 1 - 11
  • [46] INVIVO CELL SYNCHRONY IN L1210 MOUSE LEUKEMIA STUDIED WITH 5-FLUOROURACIL OR 5-FLUOROURACIL FOLLOWED BY COLD THYMIDINE INFUSION
    CAMPLEJOHN, RS
    SCHULTZE, B
    MAURER, W
    BRITISH JOURNAL OF CANCER, 1977, 35 (05) : 546 - 556
  • [47] COLIPHAGE MS2 CONTAINING 5-FLUOROURACIL .2. RNA-DEFICIENT PARTICLES FORMED IN PRESENCE OF 5-FLUOROURACIL
    SHIMURA, Y
    MOSES, RE
    NATHANS, D
    JOURNAL OF MOLECULAR BIOLOGY, 1967, 28 (01) : 95 - &
  • [48] [2-C-14] 5-FLUOROURACIL METABOLISM TO [(CO2)-C-14]
    RABINOWITZ, JL
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1991, 29 (12): : 1277 - 1282
  • [49] THE RELEASE OF 5-FLUOROURACIL FROM 1-(N-2-ETHYLMETHACRYLCARBAMOLY)-5-FLUOROURACIL MONOMERS, POLYMERS AND ACRYLATE COPOLYMERS
    HARTSOUGH, RR
    GEBELEIN, CG
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1984, 188 (AUG): : 27 - PMSE
  • [50] Preparation and passive target of 5-fluorouracil solid lipid nanoparticles
    Du, Bin
    Yan, Ying
    Li, Ying
    Wang, ShuYu
    Zhang, ZhenZhong
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2010, 15 (04) : 346 - 353